J&J: Now Master Over Mentor (MNT, JNJ)

Health and Healthcare

Published: December 1, 2008 8:21 am

Last Updated: April 28, 2020 12:15 am

If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. Mentor Corp. (NYSE: MNT) has just secured a major premium buyout this Monday morning with Johnson & Johnson (NYSE: JNJ) as the suitor.

Mentor will be acquired for approximately $1.07 billion in a cash tender offer valued at $31.00 per share.

Mentor Corporation is in the development, manufacturing, licensing, andmarketing of various products for the aesthetic and general surgerymarkets. The company will operate as a stand-alone business unit underJ&J’s ETHICON, Inc. unit, a provider of suture, mesh and otherproducts for a wide range of surgical procedures. One of Mentor’soperations it is best known for is its breast augmentation andreconstruction operations.

This is actually a near-100% buyout premium. Shares of Mentor closedat $16.15 on Friday, and the 52-week trading range is $13.33 to $40.82.

Jon C. Ogg
December 1, 2008

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention.

Finding a financial advisor who puts your interest first can be the difference between a rich retirement and barely getting by, and today it’s easier than ever. SmartAsset’s free tool matches you with up to three fiduciary financial advisors that serve your area in minutes. Each advisor has been carefully vetted, and must act in your best interests. Start your search now.

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.